4 Results for "

Mcl1-IN-9

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Mcl1-IN-9" in MCE Product Catalog:

Cat. No.: HY-128607
CAS No.: 1810769-31-3
Target:  

Bcl-2 Family

Research Areas:  

Cancer

Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM .
loading...
    loading...
Cat. No.: HY-148203
CAS No.: 1883727-31-8
Target:  

Bcl-2 Family

Research Areas:  

Cancer

Mcl-1 inhibitor 9 (example 2) is a myeloid cell leukemia 1 (Mcl-1) inhibitor with IC50 value of 0.21889 nM. Mcl-1 inhibitor 9 shows anti-tumor activity .
loading...
    loading...
Cat. No.: HY-173065
Target:  

CDK Apoptosis

Research Areas:  

Cancer

CDK9-IN-36 (Compound T7) is a potent, selective and metabolically stable CDK9 inhibitor with an IC50 value of 1.2 nM. CDK9-IN-36 effectively suppresses cell proliferation, reduces colony formation, and induces apoptosis in Osimertinib (HY-15772)-resistant NSCLC cells by downregulating Mcl-1. CDK9-IN-36 also demonstrates antitumor efficacy in a tumor xenograft model .
loading...
    loading...
Cat. No.: HY-162619
Target:  

Apoptosis CDK

Research Areas:  

Cancer

CDK9-IN-33 (compound C35) is a potent, selective and orally active CDK9 inhibitor with IC50 values of 17.44, 160, 316.30, 1771.00, >10000 nM for CDK9, CDK7, CDK2, CDK4, CDK6 respectively. CDK9-IN-33 induces apoptosis. CDK9-IN-33 decreases the protein expression of RPB1 CTD Ser2, RPB1, MCL1. CDK9-IN-33 shows anti-tumor activity .
loading...
    loading...